SLC5A2 and obesity disorder: We have also reported that, in the Otsuka Long Evans Tokushima Fatty rat (animal model of obesity) and in the SHR/NDmcr-cp animal model of metabolic syndrome, treatment of an SGLT2 inhibitor normalized the dipping pattern of blood pressure in addition to its antihypertensive effects (12, 13).